19/04/2014 03:51:31 Free Membership Login

   

Astrazeneca

Visual Financials
Company Name: AstraZeneca PLC
Ticker Symbol: AZN
WWW Address: http://www.astrazeneca.com
CEO: Pascal Soriot
No. of Employees: 51,700
Common Issue Type: CS
Business Description:AstraZeneca PLC a biopharmaceutical company focusing on six Therapy Areas: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology and Respiratory & Inflammation. It owns and operates R&D, production and marketing facilities worldwide.

 
Industry Information: DRUGS - Drug Manufacturers - Major [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 63.49 Down -0.04 - - 63.64 63.75 63.25 1033896
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 79,817.7 1,257.2 0.00 2.04 2.80 30.6 0.0 68.76 - 46.87
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close63.49$
PE Ratio - LTM30.6
Market Capitalisation79,817.7mil
Latest Shares Outstanding1,257.2mil
Earnings pS (EPS)2.04$
Dividend pS (DPS)2.80¢
Dividend Yield0.0%
Dividend Payout Ratio1%
Revenue per Employee541,064$
Effective Tax Rate18.0%
Float0.0mil
Float as % of Shares Outstanding%
Foreign Sales33,620mil
Domestic Sales8,782mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.50%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin79.5%
EBITDA Margin32.5%
Pre-Tax Profit Margin8.7%
Assets Turnover47.0%
Return on Assets (ROA)4.7%
Return on Equity (ROE)10.9%
Return on Capital Invested (ROCI)6.4%
Current Ratio1.3
Leverage Ratio (Assets/Equity)2.4
Interest Cover7.6
Total Debt/Equity (Gearing Ratio)0.45
LT Debt/Total Capital27.0%
Working Capital pS3.41$
Cash pS0.00$
Book-Value pS18.47$
Tangible Book-Value pS-2.23$
Cash Flow pS5.90$
Free Cash Flow pS4.26$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.38
Price/Tangible Book Ratio0.00
Price/Cash Flow10.6
Price/Free Cash Flow14.7
P/E as % of Industry Group42.0%
P/E as % of Sector Segment61.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Dividend Declared Date01/30/2013
Dividend Ex-Date02/12/2013
Dividend Record Date02/14/2013
Dividend Pay Date03/17/2013
Dividend Amount1900
Type of PaymentCash Payment
Dividend Rate2.80
Current Dividend Yield0.0
5-Y Average Dividend Yield3.1
Payout Ratio1.0
5-Y Average Payout Ratio45.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---1.5-11,724,0846,164,826
4 Weeks65.9861.8064.14-1.0-11,619,34732,386,954
13 Weeks68.7661.7563.59-0.1-12,253,919144,250,857
26 Weeks68.7651.0151.1224.3172,043,172255,396,516
52 Weeks68.7646.8751.2224.041,824,113459,676,615
YTD68.7658.29-8.572,202,296162,969,913
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
62.9263.4765.5359.3856.830.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue-0.040.0-0.08
Income-0.160.0-0.32
Dividend0.080.30.05
Capital Spending-0.03NA-0.12
R&D1.13NA3.54
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-13.1-13.1-16.7
Earnings %-38.4-38.40.0
EPS %-36.7-36.7-31.8
EPS $-0.47-0.47-2.32
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio9.61
Current Ratio1.4
Quick Ratio (Acid Test)1.2
Liquidity Ratio (Cash)0.61
Receivables Turnover3.1
Average Collection Period116
Working Capital/Equity21.7
Working Capital pS4.13
Cash-Flow pS7.09
Free Cash-Flow pS-2.02
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio2.99
Financial Leverage Ratio (Assets/Equity)2.3
Debt Ratio55.7
Total Debt/Equity (Gearing Ratio)0.43
LT Debt/Equity0.40
LT Debt/Capital Invested48.0
LT Debt/Total Liabilities31.6
Interest Cover9.1
Interest/Capital Invested2.42
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.47
Current P/E Ratio - LTM30.60
Enterprise Value (EV)/EBITDA10.30
Enterprise Value (EV)/Free Cash Flow-38.86
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.38
Price/Cash Flow Ratio10.6
Price/Free Cash Flow Ratio - LTM14.7
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM11.4
P/E Ratio (26 weeks ago) - LTM9.6
P/E Ratio (52 weeks ago) - LTM6.4
5-Y High P/E Ratio33.7
5-Y Low P/E Ratio16.3
5-Y Average P/E Ratio8.6
Current P/E Ratio as % of 5-Y Average P/E23
P/E as % of Industry Group42.0
P/E as % of Sector Segment61.0
Current 12 Month Normalized P/E Ratio - LTM10.6
PER SHARE FIGURES
LT Debt pS7.55
Current Liabilities pS11.15
Tangible Book Value pS - LTM-2.23
Book Value pS - LTM18.47
Capital Invested pS26.37
Cash pS - LTM0.00
Cash Flow pS - LTM5.90
Free Cash Flow pS - LTM4.26
Earnings pS (EPS)2.04
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin-9.02
Free Cash Flow Margin 5YEAR AVG8.56
Net Profit Margin22.6
Net Profit Margin - 5YEAR AVRG.0.2
Equity Productivity1.18
Return on Equity (ROE)26.7
Return on Equity (ROE) - 5YEAR AVRG.0.3
Capital Invested Productivity0.84
Return on Capital Invested (ROCI)19.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.2
Assets Productivity0.50
Return on Assets (ROA)11.8
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin79.5
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM32.5
EBIT Margin - LTM14.6
Pre-Tax Profit Margin27.6
Pre-Tax Profit Margin - 5YEAR AVRG.0.3
Effective Tax Rate18.0
Effective Tax Rate - 5YEAR AVRG.24.6
EFFICIENCY RATIOS
Cash Conversion Cycle354
Revenue per Employee541,064
Net Income per Employee122,379
Average Collection Period109
Receivables Turnover3.1
Day's Inventory Turnover Ratio245
Inventory Turnover1.5
Inventory/Sales7.4
Accounts Payble/Sales32.96
Assets/Revenue2.00
Net Working Capital Turnover5.44
Fixed Assets Turnover0.81
Total Assets Turnover0.5
Revenue per $ Cash3.63
Revenue per $ Plant4.59
Revenue per $ Common Equity1.18
Revenue per $ Capital Invested0.84
Selling, General & Adm/tive (SG&A) as % of Revenue36.3
SG&A Expense as % of Revenue - 5YEAR AVRG.0.0
Research & Devlopment (R&D) as % of Revenue18.7
R&D Expense as % of Revenue - 5YEAR AVRG.18.7

  


NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nyse azn140419 03:51